Thomas G. Wiggans - 21 Nov 2023 Form 4 Insider Report for Jasper Therapeutics, Inc. (JSPR)

Role: Director
Signature: /s/ Herb Cross, as Attorney-in-Fact
Issuer symbol: JSPR
Transactions as of: 21 Nov 2023
Net transactions value: +$6,383
Form type: 4
Filing time: 22 Nov 2023, 16:06:03 UTC
Previous filing: 20 Nov 2023
Next filing: 30 Nov 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	JSPR	Voting Common Stock	Purchase	$6,383	+10,000	+33%	$0.6383	40,000	21 Nov 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.63 to $0.65, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.63 to $0.65, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.